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In this work was target to study the stability of monoclonal antibody Nimotuzumab, which was 
modified with chelator DTPA radiolabelled with radioactive Lutetium-177 ([177Lu] Lu-hR3 (p-
SCN-Bn) DTPA). The radiochemical purity of the supplied antibody was 61%. For other uses had 
to purified. 
The chelator EDTA adds in addition for the labeled antibody. It has lower stability constant than the 
original chelating agent. He can catch the free ligand, which is excreted through the kidneys. For 
biodistribution studies is needed to ensure the highest purity that was well described by the 
distribution of radiopharmaceuticals in small bodies. Purification was used for gel permeation 
chromatography Sephadex. Purity was about 99%. 
HPLC analysis after one hour showed a small percentage of low molecular weight forms. It may be 
modified ligand with radionuclide or free radionuclide. At times long after purification the HPLC 
profile of low molecular weight fraction appeared in two peaks. They are therefore both options 
possible. The stability of the complex Lu-DTPA is relatively low. This chelating agent is used rather 
with isotopes of indium, which make more stable complex. Is mentioned that for the isotopes of 
yttrium or radiolanthanoids is preferable modification by DOTA. Between chelate and metal is 
formed stronger complex. 
